Crizanlizumab in Sickle Cell Disease

N Engl J Med. 2017 May 4;376(18):1796. doi: 10.1056/NEJMc1703162.

Authors

Kenneth I Ataga¹, Abdullah Kutlar², Julie Kanter³

Affiliations

¹ University of North Carolina, Chapel Hill, NC kataga@med.unc.edu.
² Medical College of Georgia, Augusta, GA.
³ Medical University of South Carolina, Charleston, SC.

PMID: 28467874
DOI: 10.1056/NEJMc1703162

No abstract available

Publication types

Letter
Comment

MeSH terms

Anemia, Sickle Cell*
Humans